Financial News

Financial Report: ICON

Revenues up 8% in the quarter and 6% for the year

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

ICON 4Q Revenues: $435.1 million (+8%) 4Q Earnings: $74.3 million (+17%) FY Revenues: $1.7 billion (+6%)   FY Earnings: $269.3 million (+12%) Comments: Backlog grew 8% for the year to $4.2 billion, constant currency revenues increased 6% to $1.7 billion. The company had an operating margin of 19.5% in 2016. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters